From mboxrd@z Thu Jan 1 00:00:00 1970 From: Mail Delivery System Subject: Mail delivery failed: returning message to sender Date: Thu, 05 Oct 2006 09:58:04 -0700 Message-ID: Mime-Version: 1.0 Content-Type: text/plain; charset="us-ascii" Content-Transfer-Encoding: 7bit Return-path: List-Unsubscribe: , List-Archive: List-Post: List-Help: List-Subscribe: , Sender: alsa-devel-bounces@lists.sourceforge.net Errors-To: alsa-devel-bounces@lists.sourceforge.net To: alsa-devel@lists.sourceforge.net List-Id: alsa-devel@alsa-project.org This message was created automatically by mail delivery software. A message that you sent could not be delivered to one or more of its recipients. This is a permanent error. The following address(es) failed: alsa-devel@lists.sourceforge.net SMTP error from remote mailer after RCPT TO:: host mail.sourceforge.net [66.35.250.206]: 451-Could not complete sender verify callout 451-Could not complete sender verify callout for 451-. 451-The mail server(s) for the domain may be temporarily unreachable, or 451-they may be permanently unreachable from this server. In the latter case, 451-you need to change the address or create an MX record for its domain 451-if it is supposed to : retry timeout exceeded ------ This is a copy of the message, including all the headers. ------ Return-path: Received: from [219.128.237.98] (helo=219.128.237.98) by externalmx-1.sourceforge.net with esmtp (Exim 4.41) id 1GU2D2-0001l5-97 for alsa-devel@lists.sourceforge.net; Sun, 01 Oct 2006 07:22:25 -0700 Received: from [171.171.210.211] (helo=[6644245465]) by 219.128.237.98 with smtp (Exim 4.60 (FreeBSD)) (envelope-from ) id rKO-BPUq6M-dh for alsa-devel@lists.sourceforge.net; Sun, 01 Oct 2006 22:22:08 +0800 Received: from diamondsystems.com (8178470400 [258737474]) by DIAMOND1.INETU.NET (Qmailv1) with ESMTP id YEX7054AI6K for ; Sun, 01 Oct 2006 15:30:26 +0200 Date: Sun, 01 Oct 2006 15:30:26 +0200 From: " Mcdonald" X-Mailer: Pegasus Mail for Win32 (v2.53/R1) X-Priority: 3 Message-ID: <5763726108124.2006100115302641251631@diamondsystems.com> To: alsa-devel@lists.sourceforge.net Subject: sir, said, confusedly, I guess not a colony, the MIME-Version: 1.0 Content-Type: text/plain; charset=windows-1258 Content-Transfer-Encoding: 7bit X-Spam-Score: 3.5 (+++) X-Spam-Report: Spam Filtering performed by sourceforge.net. See http://spamassassin.org/tag/ for more details. Report problems to https://sf.net/tracker/?func=add&group_id=1&atid=200001 0.0 RCVD_BY_IP Received by mail server with no name 1.5 RCVD_NUMERIC_HELO Received: contains an IP address used for HELO 0.0 SF_CHICKENPOX_PERIOD BODY: Text interparsed with . 0.0 SF_CHICKENPOX_MINUS BODY: Text interparsed with - 0.0 SF_CHICKENPOX_AMPERSAND BODY: Text interparsed with & 1.8 STOCK_ALERT BODY: Offers a alert about a stock 0.0 SF_CHICKENPOX_APOSTROPHE BODY: Text interparsed with ' 0.1 RCVD_IN_SORBS_DUL RBL: SORBS: sent directly from dynamic IP address [219.128.237.98 listed in dnsbl.sorbs.net] HOT STOCK ALERT - THIS ONE IS STILL CLIMBING THE STOCK CHARTS ALERT -- BREAKING MARKET NEWS REPORT ---- PGCN.OB Company: Pingchuan Pharmaceutical Inc. Ticker: PGCN.OB Current Price: $.26 5-Day Target: $1.5 - $2 Rating: 10(10) Recommendation: S T R 0 N G - B U Y !! This quick rising stock is a good long term winner. This stock is going high due to superb business solutions and creative partnerships in the business world. Could this company be the next PFIZER?? Pingchaun Pharmaceuticals disributes its medications to over 50 percent of CHINA and has a tremendous presence via exports to U.S.A, Russia, Japan and South-Eastern Asia. They have partnerships with the biggest drugstores, equivalent in the US to SAV-ON, CVS, RITE-AID, etc. With BIG NEWS anticipated this coming WEEK we strongly advise you to get in EARLY and issue a 10/10 Alert. About Pingchuan Pharmaceutical Inc. Pingchuan Pharmaceutical Inc. ("PINGCHUAN") is a modernized pharmaceutical manufacturer with first-class medical R&D ability, pioneered medicine products, and well-established marketing network. Since its establishment, PINGCHUAN has focused its businesses on diabetes medicine and its medical products. The products of PINGCHUAN include health care products, varieties of medicine, as well as medical apparatus. Kang Da Glycosuria Capsule is a successful product of PINGCHUAN for treating diabetes, which was first developed in 1998 and introduced to the market in 2001. PINGCHUAN has well-established marketing network and sale branches, which include about 180,000 retail pharmacies /drugstores across China, agency network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an, special counter sale at drug chain stores in key regions, residence community clinic sale and promotion, as well as internet marketing through the company's website. The marketing network of PINGCHUAN covers more than 50 percent districts of China and exports to US, Japan, Russia, and south-eastern Asia. Dont miss the boat, this is a new issue, is thinly traded and could move up quickly. We anticipate that shares of PGCN will be much higher in the short-term. ACT NOW! Remember the gains from our recent recommendations... Do not miss out, Put PGCN.OB on your radar's now. Good luck and trade out at the top!! ------------------------------------------------------------------------- Take Surveys. Earn Cash. Influence the Future of IT Join SourceForge.net's Techsay panel and you'll get the chance to share your opinions on IT & business topics through brief surveys -- and earn cash http://www.techsay.com/default.php?page=join.php&p=sourceforge&CID=DEVDEV